atropineatropine-treatedpremyopialow myopiamyopia
…e were no significant differences in myopia progression between atropine and placebo treated eyes, there were trends towards less myopic…
10,506articles mentioning drugs
58,393drug mentions
9,496distinct drugs extracted
0%of mentions human-reviewed
All extracted drugs
Showing 1,321–1,380 of 9,496, ordered by supporting articles. Choose a drug to see its evidence.
ascorbic acid3calcitriol3canakinumab3chenodeoxycholic acid3cisplatin-induced3condoms3contraceptive pill3cytarabine3dextran sodium sulfate3diamorphine3diazinon3direct oral anticoagulants3donepezil3drug3elranatamab3endothelin receptor antagonists3etoricoxib3famotidine3flunarizine3glucagon-like peptide-1 receptor agonist3glucose-lowering medications3illicit drugs3immunosuppressive agents3immunotherapies3intra-arterial verapamil3intrathecal opioids3intravenous acyclovir3intravenous fentanyl3intravenous ketamine3intravenous thrombolysis3isocyanates3long-acting nitrates3mRNA vaccines3medicine3neuromodulators3new drug3new drugs3nitroglycerin3opiates3oral doxycycline3pharmaceuticals3piperacillin–tazobactam3prescription medications3pulse oximetry3ramipril3reslizumab3sedatives3small molecules3taxane3tenofovir disoproxil3tepotinib3tetracyclines3thyroid-stimulating hormone3tissue plasminogen activator3topical antibiotics3tricyclic antidepressants3trimethoprim/sulfamethoxazole3trimethoprim–sulfamethoxazole3vitamin K antagonists3weight loss drugs3
Articles mentioning drugs
10,506 articles · page 162 of 876adalimumabmethotrexatejuvenile idiopathic arthritisnon-infectious uveitisJIANIUtertiary UK centrespecialist paediatric rheumatology service
…ever, the development of neutralising antibodies may compromise adalimumab’s efficacy. This study investigated the incidence and clinical …
99.4%
inclisiranevolocumabalirocumabatorvastatinrosuvastatinperipheral arterial diseaseischaemic heart diseaseischaemic cerebrovascular diseaseheterozygous familial hypercholesterolaemiaHeFH+2 more
…itors (PCSK9 inhibitors), including evolocumab, alirocumab, and inclisiran, are potent lipid-lowering agents indicated for patients at hig…
atropine sulfateatropinemyopiaHospital pharmacy
….060 5.16 ± 0.012 Abstract 3PC-005 Tabel 3Average osmolality of atropine sulfate eye dropsBatch 4-week in use (mosm/kgH2O) 14-week stability (mo…
PipTazpiperacillin/tazobactamDepartment of Health and Social CarePharmacy Aseptic ServicesRegional GovernmentPharmacy Aseptic Services
…o administer (RTA) doses to Pharmacy Aseptic Services utilising PipTaz multidose bags.Aim and Objectives The aim of this research was …
OxaliplatinPaclitaxelFluorouracilrepetitive stress injuries
… container Withdrawal force (Kg) (SD) Insertion force (Kg) (SD) Oxaliplatin (100 mg/20 mL) 200 40 50 IV bag 4.22 (1.60) 5.80 (2.71) Oxalipl…
paclitaxelcarboplatincyclophosphamidefluorouracildoxorubicinKIRO-Oncologymusculoskeletal disorders
…). The drugs considered most difficult to prepare manually were paclitaxel (35%), fluorouracil (13%), and cyclophosphamide (12%), while th…
bosentandaratumumabazacitidineibrutinibnintedanibrare diseasesRDORPHANETnational health authorities
… (14.8%), nintedanib (11.3%), ibrutinib (10%), azacitidine, and bosentan (7.8%). OD distribution by ATC group was dominated by L (n=19),…
propranololmetoprololbisoprololhaemangiomasarterial hypertensionDivision of PaediatricsarrhythmiasATC group C07congenital malformations of the circulatory systemtachycardia
…d for use in children: metoprolol for arterial hypertension and propranolol for arrhythmias and haemangiomas. The use of these medications …
Inclisiranezetimibehypercholesterolaemiatertiary hospitalhypertriglyceridemia
… included (40% women; 60±7 years), all in secondary prevention. Inclisiran was indicated for failure to reach LDL-C targets despite optima…
argatrobanheparin-induced thrombocytopeniaICUHIThepatic dysfunctionExtracorporeal supportECMO
…e the impact of organ dysfunction and extracorporeal support on argatroban dosing requirements in critically ill patients.Material and Met…
99.3%
Pembrolizumablung cancermelanoma
…ced or metastatic disease, with 75% presenting brain metastases.Pembrolizumab discontinuation was due to disease progression (39%), immune-re…